Australia - English - Department of Health (Therapeutic Goods Administration)

premalife pty ltd t/a natural vitality australia - ascorbic acid, quantity: 400 mg/g; hesperidin, quantity: 95 mg/g; calcium ascorbate dihydrate, quantity: 100 mg/g; magnesium phosphate pentahydrate, quantity: 95 mg/g (equivalent: magnesium, qty 19.625 mg/g); calcium phosphate, quantity: 50 mg/g (equivalent: calcium, qty 19.5 mg/g); zinc sulfate monohydrate, quantity: 1.45 mg/g (equivalent: zinc, qty 529 microgram/g) - powder, oral - excipient ingredients: fructose; glucose monohydrate; silicon dioxide; stevia rebaudiana; flavour - maintain/support immune system health ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve symptoms of common cold

Australia - English - Department of Health (Therapeutic Goods Administration)

glen gillard (t/a wonder foods) - ascorbic acid,biotin,choline bitartrate,cyanocobalamin,dexpanthenol,folic acid,inositol,lysine hydrochloride,nicotinamide,pyridoxine hydrochloride,riboflavin sodium phosphate,thiamine hydrochloride,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

glen gillard (t/a wonder foods) - magnesium phosphate,potassium phosphate - dibasic -

Australia - English - Department of Health (Therapeutic Goods Administration)

glen gillard (t/a wonder foods) - magnesium phosphate -

Australia - English - Department of Health (Therapeutic Goods Administration)

glen gillard (t/a wonder foods) - calcium hydrogen phosphate -

European Union - English - EMA (European Medicines Agency)

glenmark arzneimittel gmbh - olanzapine - schizophrenia; bipolar disorder - psycholeptics - adultsolanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode. in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

European Union - English - EMA (European Medicines Agency)

glenmark arzneimittel gmbh - olanzapine - schizophrenia; bipolar disorder - psycholeptics - adultsolanzapine is indicated for the treatment of schizophrenia.olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.olanzapine is indicated for the treatment of moderate to severe manic episode. in patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Kenya - English - Pharmacy and Poisons Board

glenmark pharmaceuticals ltd glenmark house, hdo-corporate building wing, - glycopyrrolate usp - oral powder - glycopyrronium powder 50 mcg - glycopyrronium bromide

Kenya - English - Pharmacy and Poisons Board

glenmark pharmaceuticals ltd hdo-corporate building, wing a, b, d sawant marg, - glycopyrrolate usp & formoterol fumarate - capsule - 12.5mcg & 12mcg - formoterol and glycopyrronium bromide

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glenmark pharmaceuticals (malaysia) sdn. bhd. - glycopyrronium bromide; formoterol fumarate -